U S PHYSICAL THERAPY INC /NV Lease, Cost
U S PHYSICAL THERAPY INC /NV (USPH) reported Lease, Cost of $16.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-08-07
- U S PHYSICAL THERAPY INC /NV lease, cost for the quarter ending 2026-06-30 was $16.05M, a 8.78% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV lease, cost for the quarter ending 2026-03-31 was $16.04M, a 11.20% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV lease, cost for the quarter ending 2025-12-31 was $15.71M, a 17.44% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV lease, cost for the quarter ending 2025-09-30 was $15.06M, a 14.84% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV lease, cost for fiscal 2025 was $59.95M, a 14.92% increase from fiscal 2024.
- U S PHYSICAL THERAPY INC /NV lease, cost for fiscal 2024 was $52.17M, a 6.86% increase from fiscal 2023.
- U S PHYSICAL THERAPY INC /NV lease, cost for fiscal 2023 was $48.82M, a 14.91% increase from fiscal 2022.
- U S PHYSICAL THERAPY INC /NV lease, cost for fiscal 2022 was $42.49M, a 5.60% increase from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 3 month as first filed | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 9 month as first filed | Lease, Cost 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16.05M 10-Q · filed 2026-08-07 | $32.09M 10-Q · filed 2026-08-07 | $47.80M derived: sum of 3 quarters · filed 2026-08-07 | $62.87M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2026-03-31 | $16.04M 10-Q · filed 2026-05-08 | $31.75M derived: sum of 2 quarters · filed 2026-05-08 | $46.81M derived: sum of 3 quarters · filed 2026-05-08 | $61.57M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-12-31 | $15.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $30.77M derived: sum of 2 quarters · filed 2026-02-27 | $45.53M derived: sum of 3 quarters · filed 2026-08-07 | $59.95M 10-K · filed 2026-02-27 | ||
| 2025-09-30 | $15.06M 10-Q · filed 2025-11-07 | $29.82M derived: sum of 2 quarters · filed 2026-08-07 | $44.24M 10-Q · filed 2025-11-07 | $57.62M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-06-30 | $14.76M 10-Q · filed 2026-08-07 | $29.18M 10-Q · filed 2026-08-07 | $42.56M derived: sum of 3 quarters · filed 2026-08-07 | $55.67M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-03-31 | $14.42M 10-Q · filed 2026-05-08 | $27.80M derived: sum of 2 quarters · filed 2026-05-08 | $40.92M derived: sum of 3 quarters · filed 2026-05-08 | $54.00M derived: sum of 4 quarters · filed 2026-05-08 | ||
| 2024-12-31 | $13.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $26.50M derived: sum of 2 quarters · filed 2026-02-27 | $39.58M derived: sum of 3 quarters · filed 2026-02-27 | $52.17M 10-K · filed 2026-02-27 | ||
| 2024-09-30 | $13.12M 10-Q · filed 2025-11-07 | $26.20M derived: sum of 2 quarters · filed 2025-11-07 | $38.79M 10-Q · filed 2025-11-07 | $51.47M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-06-30 | $13.08M 10-Q · filed 2025-08-08 | $25.67M 10-Q · filed 2025-08-08 | $38.36M derived: sum of 3 quarters · filed 2026-02-27 | $50.66M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-03-31 | $12.59M 10-Q · filed 2025-05-09 | $25.27M derived: sum of 2 quarters · filed 2026-02-27 | $37.57M derived: sum of 3 quarters · filed 2026-02-27 | $49.64M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2023-12-31 | $12.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $24.99M derived: sum of 2 quarters · filed 2026-02-27 | $37.05M derived: sum of 3 quarters · filed 2026-02-27 | $48.82M 10-K · filed 2026-02-27 | ||
| 2023-09-30 | $12.30M 10-Q · filed 2024-11-08 | $24.36M derived: sum of 2 quarters · filed 2024-11-08 | $36.14M 10-Q · filed 2024-11-08 | $46.02M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2023-06-30 | $12.07M 10-Q · filed 2024-08-14 | $23.84M 10-Q · filed 2024-08-14 | $33.73M derived: sum of 3 quarters · filed 2025-03-03 | $44.72M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2023-03-31 | $11.77M 10-Q · filed 2024-05-08 | $21.66M derived: sum of 2 quarters · filed 2025-03-03 | $32.65M derived: sum of 3 quarters · filed 2025-03-03 | $43.60M derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2022-12-31 | $9.89M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $20.88M derived: sum of 2 quarters · filed 2025-03-03 | $31.83M derived: sum of 3 quarters · filed 2025-03-03 | $42.49M 10-K · filed 2025-03-03 | ||
| 2022-09-30 | $10.99M 10-Q · filed 2023-11-08 | $21.95M derived: sum of 2 quarters · filed 2023-11-08 | $32.60M 10-Q · filed 2023-11-08 | $43.03M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | $10.95M 10-Q · filed 2023-08-09 | $21.61M 10-Q · filed 2023-08-09 | $32.03M derived: sum of 3 quarters · filed 2024-02-29 | $42.26M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | $10.66M 10-Q · filed 2023-05-05 | $21.08M derived: sum of 2 quarters · filed 2024-02-29 | $31.30M derived: sum of 3 quarters · filed 2024-02-29 | $41.19M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2021-12-31 | $10.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $20.65M derived: sum of 2 quarters · filed 2024-02-29 | $30.53M derived: sum of 3 quarters · filed 2024-02-29 | $40.24M 10-K · filed 2024-02-29 | ||
| 2021-09-30 | $10.22M 10-Q · filed 2022-11-08 | $20.11M derived: sum of 2 quarters · filed 2022-11-08 | $29.82M 10-Q · filed 2022-11-08 | $39.26M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-06-30 | $9.88M 10-Q · filed 2022-08-08 | $19.59M 10-Q · filed 2022-08-08 | $29.03M derived: sum of 3 quarters · filed 2023-02-28 | $38.33M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-03-31 | $9.71M 10-Q · filed 2022-05-09 | $19.15M derived: sum of 2 quarters · filed 2023-02-28 | $28.44M derived: sum of 3 quarters · filed 2023-02-28 | $37.99M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-12-31 | $9.44M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $18.73M derived: sum of 2 quarters · filed 2023-02-28 | $28.28M derived: sum of 3 quarters · filed 2023-02-28 | $37.92M 10-K · filed 2023-02-28 | ||
| 2020-09-30 | $9.29M 10-Q · filed 2021-11-09 | $18.84M derived: sum of 2 quarters · filed 2021-11-09 | $28.48M 10-Q · filed 2021-11-09 | $46.90M derived: sum of 4 quarters · filed 2021-11-09 | ||
| 2020-06-30 | $9.54M 10-Q · filed 2021-08-09 | $19.18M 10-Q · filed 2021-08-09 | $37.60M derived: sum of 3 quarters · filed 2021-08-09 | $47.15M derived: sum of 4 quarters · filed 2021-08-09 | ||
| 2020-03-31 | $9.64M 10-Q · filed 2021-05-10 | $28.06M derived: sum of 2 quarters · filed 2021-05-10 | $37.61M derived: sum of 3 quarters · filed 2021-05-10 | $47.16M derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2019-12-31 | $18.42M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $27.97M derived: sum of 2 quarters · filed 2021-03-01 | $37.52M derived: sum of 3 quarters · filed 2021-03-01 | $37.51M 10-K · filed 2021-03-01 | ||
| 2019-09-30 | $9.55M 10-Q · filed 2020-11-06 | $9.04M 10-Q · filed 2019-11-08 | $19.10M derived: sum of 2 quarters · filed 2020-11-06 | $19.09M 10-Q · filed 2020-11-06 | $28.14M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $9.55M 10-Q · filed 2020-08-07 | $19.09M 10-Q · filed 2020-08-07 | ||||
| 2019-03-31 | $9.54M 10-Q · filed 2020-05-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |